Business
New commercialisation partner in Asia Pacific
New commercialisation partner in Asia Pacific.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \n \n \n OptiBiotix Health plc\n \n \n \n \n (\"OptiBiotix\" or the \"Company\")\n \n \n \n \n \n \n \n \n \n New\n \n \n commercialisation\n \n \n partner in Asia Pacific\n \n \n \n \n \n \n \n \n OptiBiotix Ltd, a wholly owned subsidiary of OptiBiotix Health plc\n (AIM: OPTI) and a life sciences business developing patented science and human study-based compounds that modulate the microbiome to address a range of health related issues such as metabolic syndrome and diabetes, systemic low-grade inflammation, obesity, cardiovascular disease, high cholesterol and healthy aging\n announces it has signed a services agreement with Nutraconnect for the Asia Pacific (\"APAC\") Region. Nutraconnect will develop and implement the go-to-market strategy for prebiotics ingredients SlimBiome\n ®\n and LeanBiome\n ®\n .\n \n \n \n \n \n Nutraconnect Pte., Ltd. (\"Nutraconnect\"), is a nutraceutical business growth acceleration service headquartered in Singapore. The company provides end-to-end solutions for global nutraceutical ingredient manufacturers that are looking to establish a foundation for sustainable growth in the fragmented but growing APAC market. Nutraconnect possesses a wealth of experience in bringing innovative and science backed nutraceutical ingredients successfully to the market in the region.\n \n \n \n \n \n \n René Kamminga,\n \n \n C\n \n EO of OptiBiotix Limited, commented\n : \"\n Nutraconnect\n \n is an important extension of our commercial experience and reach in the APAC region.\n \n Nutraconnect\n \n brings unique regulatory and commercial experience combined with an extensive distribution and agency network in the various countries in the region. This partnership will help expedite the commercialisation of our prebiotic technologies in strategic countries in the region. At the same time, it will allow OptiBiotix to focus primarily on established key accounts and building up our North American presence and sales.\"\n \n \n \n \n \n \n \n \n The Directors of the Company are responsible for the release of this announcement.\n \n \n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n \n \n \n \n \n OptiBiotix Health plc\n \n \n \n \n \n \n www.optibiotix.com\n \n \n \n \n \n \n \n \n \n \n Stephen O'Hara, Chief Executive\n \n \n \n \n \n Contact...